🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our Editorial in Haematologica ➡️ Not all central nervous system lymphomas are created equal haematologica.org/article/view/h… about this important study describing the biology of secondary CNS lymphoma ➡️haematologica.org/article/view/h… Sylvester Comprehensive Cancer Center

Ongoing efforts from our pulmonary team working to understand pulmonary toxicities from cancer #immunotherapy. Need to have better risk stratification, predictors, and treatment for pneumonitis. Ohio State Medical Oncology The Ohio State University Wexner Medical Center The James Ohio State Internal Medicine Residency academic.oup.com/oncolo/article…

Always inspiring to see IITs - especially ones that include #rareTumors go the distance & make an impact! And exciting to see our GU section Chief Amir Mortazavi as last author. Congratulations to Amir, Andrea Apolo, M.D. & all the investigators! The James Ohio State Medical Oncology

When I was accepted to med school in 2008 I told my mom, a life long tennis fan, that I would take her to Wimbledon one day. Last year, she was diagnosed with a high grade liposarcoma, which raised the Wimbledon urgency a bit. Radiation, multiple surgeries, and my own cardiac

We are deeply saddened to report the passing of Dr. Bhuvaneswari Ramaswamy, a renowned and beloved The James breast medical oncologist and researcher who greatly enriched our cancer program before succumbing to breast cancer following a heroic battle.go.osu.edu/bhuvana

📢 New paper from Katharine Collier, MD in Annals of Oncology "Confirmation of large BRCA2 reversion deletions leading to reconstituted in-frame transcripts detected via circulating tumor DNA" annalsofoncology.org/article/S0923-… The James Ohio State Medical Oncology

Today, we awarded CU Cancer Center and the sarcoma team as the first #TGCT Center of Excellence. Their talks at #TDOL were exceptional and we are lucky for their dedication to our community. Thank you Breelyn Wilky, MD 🎗 Drs Nathan Donaldson, Steven Thorpe, Alessandra Maleddu and Michael Clay

Hello Friends , please consider donating to my race against cancer ! pelotonia.org/profile/GT0026

Dumont Syndrome= #GIST plus #Desmoid Tumor. First Description of the Clinical Activity of Avapritinib in Sporadic Mesenteric Desmoid Tumor. ⁦Gabriel Tinoco⁩ ⁦Desmoid Tumor Research Foundation⁩ ⁦The Life Raft Group⁩ pubmed.ncbi.nlm.nih.gov/39135981/

📝New publication from Dan Spakowicz, Dennis Grencewicz & Laura Chambers: From poo to promise: Fecal microbiota transplants support immunotherapy re-sensitization in solid tumors doi.org/10.1016/j.chom…

📝New publication from Gabriel Tinoco & colleagues: First Description of the Clinical Activity of Avapritinib in Sporadic Mesenteric Desmoid Tumor pubmed.ncbi.nlm.nih.gov/39135981/

Hey, watch out! Here it is our review on the management of soft tissue #sarcoma published on Annals of Surgical Oncology A collaborative effort from Hopital Maisonneuve-Rosemont & Istituto Tumori Mai-Kim Gervais and I go through the approach to the main histologic types and sites.

👏Congratulations to Dr. Claire Verschraegen, Dwight Owen & Dr. Robert Wesolowski on their recent R25 funding!

Valerie Grignol & Dr. David Liebner at the annual Steps for Sarcoma event benefitting The James sarcoma research & care!

Our final in-person U.S. GIST Day of Learning for 2024 was last Saturday at Ohio State University w/GIST experts Drs. Tinoco, Iwenofu, Liebner & Grignol presenting. Check out upcoming educational events at: bit.ly/LRGEvents2024 Gabriel Tinoco Valerie Grignol The James

Congratulations to our Medical Oncology Division team members promoted to Associate Professor and Professor! Very well deserved! Nice ceremony by our Department Medicine Yuanquan Yang , Sameek Roychowdhury, Alayna Tackett, Mathew Cherian, Ohio State Medical Oncology The Ohio State University College of Medicine

@OSUCCC_JAMES, #PIIO researcher, Dr. Dan Spakowicz, is discussing how lifestyle-based modifications of the #microbiome can improve #cancer treatment outcomes—linking diet, microbes, and #immunotherapy response. #Host_Microbe in the Digestive Tract Symposium.

Today family picture with some of the 87 amazing faculty of our Division of Medical Oncology at The James CCC. Very honored to be part and lead this incredible team! Ohio State Medical Oncology The James The Ohio State University College of Medicine